Mayuresh Raut

About

Mr. Mayuresh K. Raut is working as Assistant Professor (Pharmaceutical Chemistry) at PCET'S School of Pharmacy, Pimpri Chinchwad University . He holds a rich academic experience of 18.6 years. He earned his M. Pharm (First Class with Distinction in Pharmaceutical Chemistry) and B. Pharm (First Class) from AISSMS College of Pharmacy, University of Pune, Maharashtra, India. He secured First Rank in University of Pune at Master of Pharmacy (Pharmaceutical Chemistry). He has also completed Professional Diploma inClinical Research (PDCR). He qualified GATE and National Level Pharmacy Talent Search Examination (AIR-26). He has 9 international publications to his credit in peer reviewed journals, has authored 8 books, filed 2 International Patents, 5 Indian Patents, 2 Design Patents to his credit, has h-index 6. He has fetched research grant worth 2.70 lacs from SPPU. He has been nominated in Marquis Who’s Who List 2012 (29th edition). He has completed Innovation Ambassador Training (Basic & Advanced Level) conducted by MoE’s Innovation Cell & AICTE, New Delhi. He was awarded Summer Research Fellowship by Indian Academy of Sciences (IAS), Bangalore at IIT Mumbai. He is recipient of Young Researcher Award, National Education Excellence Achievers Award, Young Researcher by (RSquareL), Young Faculty Award, Eminent Teacher Award. He is Life Member of APTI, ISTE, SPER,RSH, APP.

Employment

• PCET's School of Pharmacy, Pimpri Chinchwad University Assistant Professor
  2023 - Present
• Sinhgad Institute of Pharmaceutical Sciences Assistant Professor
  2007 - 2023

Education

• AISSMS College of Pharmacy M.Pharmacy
  2006 - 2007
• AISSMS College of Pharmacy B.Pharmacy
  2000 - 2005

Projects & Funding

Projects & funding information is unavailable.

Publications (10)

• Stimuli-Responsive Carbon Nanotubes for On-Demand Cancer Therapy: A Review
  AAPS PharmSciTech 2026 DOI: 10.1208/s12249-026-03391-w
  +Save
• An overview of strategies used for increasing Glycyrrhizin biosynthesis
  Discover Industrial Chemistry and Materials 2026 DOI: 10.1007/S44508-026-00008-9
  +Save
• Chemical Innovation: The Design, Synthesis, and Pharmacological Evaluation of Novel Heterocyclic Compounds
  Current Bioactive Compounds 2026 DOI: 10.2174/0115734072376668250704075925
  +Save
• Evaluation of antiallergic and anti-anaphylactic activity of ethanolic extract of Sanseveiria trifasciata leaves (EEST) in rodents
  Journal of Ethnopharmacology 2012 DOI: 10.1016/J.JEP.2012.05.007
  +Save
• QSAR studies of phthalazinones: novel inhibitors of poly (ADP-ribose) polymerase
  Medicinal Chemistry Research 2011 DOI: 10.1007/S00044-010-9414-2
  +Save
• Synthesis and Pharmacological Evaluation of Novel 1-(2-(Benzoyl-Substituted-2-phenyl-1H-Indol-5-Carbony) Hydrazinyloxy) Vinyl Nitrate Derivatives as Potent Non-Ulcerogenic, Analgesic and Anti-Inflammatory Agents
  Medicinal Chemistry 2010 DOI: 10.2174/1573406411006040211
  +Save
• Design, synthesis and evaluation of antiinflammatory, analgesic and ulcerogenicity studies of novel S-substituted phenacyl-1,3,4-oxadiazole-2-thiol and Schiff bases of diclofenac acid as nonulcerogenic derivatives
  Bioorganic & Medicinal Chemistry 2008 DOI: 10.1016/J.BMC.2007.11.014
  +Save
• ANTI-INFLAMMATORY, ANALGESIC, ULCEROGENIC ACTIVITIES OF SOME NEW NON-ACIDIC DICLOFENAC AND 1, 3, 4- OXADIAZOLE DERIVATIVES IN ANIMAL MODELS
  2007
  +Save
• Anti-inflammatory, analgesic, ulcerogenic activities of some new non-acidic diclofenac and 1,3,4-oxadiazole derivatives in animal models
  Pharmacologyonline 2007
  +Save
• Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents
  Bioorganic & Medicinal Chemistry 2007 DOI: 10.1016/J.BMC.2007.04.003
  +Save